BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, January 14, 2026
Home » Topics » Briefs » In the clinic

In the clinic
In the clinic RSS Feed RSS

In the clinic for July 1, 2025

July 1, 2025
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Cognito, Elutia, Implantica, Novocure, Stereotaxis.
Read More

In the clinic for July 1, 2025

July 1, 2025
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alto, AN2, Argenx, Artelo, Ashvattha, Aurinia, Biogen, Celcuity, Chemomab, Corbus, Hansa, Idorsia, Inmune, InvIos, Moderna, OS.
Read More

In the clinic for July 1, 2025

July 1, 2025
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Alebund, Brightgene, Immutep, Innovent, Mindrank, Qbiotics.
Read More

In the clinic for June 30, 2025

June 30, 2025
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Foldax.
Read More

In the clinic for June 30, 2025

June 30, 2025
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alebund, Altimmune, Alto, Crispr, Edgewise, Gri, I-Mab, Invivyd, Lisata, Metabolics, Opus, Pfizer, Viatris.
Read More

In the clinic for June 27, 2025

June 27, 2025
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alebund, Altimmune, Alto, Crispr, Edgewise, Gri, I-Mab, Invivyd, Lisata, Metabolics, Opus, Pfizer, Viatris.
Read More

In the clinic for June 26, 2025

June 26, 2025
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Acaris, Ambry, Moleculight, Ossdsign, Vivos.
Read More

In the clinic for June 26, 2025

June 26, 2025
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alvotech, Aprea, Assembly, Biogen, Blue Earth, Calcimedica, Hemab, Hoth, Innovent, Ionis, Kashiv, Phio, Qbiotics, Soleno.
Read More

In the clinic for June 25, 2025

June 25, 2025
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Cardiosense, Genedx, Glucotrack, Onetwo Analyics.
Read More

In the clinic for June 25, 2025

June 25, 2025
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Abeona, Actuate, Biomarin, Breye, Brightgene, Corcept, Immunic, Lineage Cell, Mindrank, Nektar, Nuvalent, Perfuse, Rivus, Roche, Sana, Sangamo, Stuart, Thermosome, Veru.
Read More
Previous 1 2 … 23 24 25 26 27 28 29 30 31 … 313 314 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan 14, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Jan. 14, 2026.
  • 3D rendering of antibody drug conjugated with cytotoxic payload

    ADCs’ breakout 2025 and their still-unfinished potential

    BioWorld
    Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
  • Lung cancer illustration

    LINC01116 has prognostic value in lung cancer, study shows

    BioWorld MedTech
    Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
  • SERPINB1 as potential biomarker for spinocerebellar ataxia type 2

    BioWorld Science
    Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing